FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to an anticancer compound of formula 
.
EFFECT: what is presented is the new anticancer compound possessing a high selectivity index in relation to cancer cell as compared to human and animal normal phenotype cells to be used in medicine and veterinary science for treating cancer and preventing metastases, including those including osseous lesion.
2 ex, 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| N-[3-OXOLUP-20(29)-ENE-28-OIL]-2,2,6,6-TETRAMETHYLPIPERIDINE-4-YLAMINE WITH CYTOTOXIC ACTIVITY IN RESPECT OF HUMAN TUMOUR CELLS | 2017 |
|
RU2641900C1 |
| PEPTIDE, POSSESSING ANTI-TUMOR AND ANTI-METASTATIC ACTIVITY, AND FINISHED DOSAGE FORM BASED THEREON | 2018 |
|
RU2682039C1 |
| UNIVERSAL PROMOTER FOR EXPRESSION OF THERAPEUTIC GENES IN MAMMALIAN CELLS | 2013 |
|
RU2551784C1 |
| ANTITUMOR AGENT | 2015 |
|
RU2609871C1 |
| METHOD OF OBTAINING SYSTEM OF DIRECTED DELIVERY OF PROTEIN MOLECULES (ONCOLYTIC PROTEINS) INTO TUMOUR CELLS BASED ON ACTIVATED LYMPHOCYTES | 2013 |
|
RU2552609C1 |
| SODIUM COBALT POLYGALACTURONATE WITH ANTITUMOR ACTIVITY | 2023 |
|
RU2794885C1 |
| TITANIUM IMPLANT WITH THE FUNCTION OF LOCAL IMMUNOTHERAPY FOR OSTEORECONSTRUCTIVE SURGERY AND PREVENTION OF LOCAL RECURRENCE OF ONCOLOGICAL DISEASE AND METHOD FOR ITS MANUFACTURE | 2021 |
|
RU2779367C1 |
| FLUORINE-CONTAINING BENZYLATED ISATINS WITH ANTITUMOR ACTIVITY | 2022 |
|
RU2802016C1 |
| RECOMBINANT PLASMID DNA PAD5-F CARRYING OF ADENOVIRUS TYPE 5 GENOME FRAGMENT WITH DELETION IN GENE E1B-55K AND STRAIN OF MUTANT ADENOVIRUS ADE 12 EXHIBITING SELECTIVE ANTITUMOR ACTIVITY | 2001 |
|
RU2194755C2 |
| ANTI-TUMOUR AGENT BASED ON RECOMBINANT VACCINIA VIRUS STRAIN AND METHOD FOR PRODUCTION THEREOF | 2019 |
|
RU2730657C1 |
